These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 35558546

  • 1. Pre-test Cortisol Levels in Predicting Short Synacthen Test Outcome: A Retrospective Analysis.
    Ravindran R, Carter JL, Kumar A, Capatana F, Khan IN, Adlan MA, Premawardhana LD.
    Clin Med Insights Endocrinol Diabetes; 2022; 15():11795514221093316. PubMed ID: 35558546
    [Abstract] [Full Text] [Related]

  • 2. Can a random serum cortisol reduce the need for short synacthen tests in acute medical admissions?
    Kadiyala R, Kamath C, Baglioni P, Geen J, Okosieme OE.
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):378-80. PubMed ID: 20488874
    [Abstract] [Full Text] [Related]

  • 3. "A morning cortisol is the most effective clinical predictor of short synacthen test outcome": A tertiary care centre experience.
    Mathara Diddhenipothage SAD, Beck KJ, Loo H, Amiyangoda GK, Pofi R, Tomlinson JW, Pal A.
    Clin Endocrinol (Oxf); 2023 Aug; 99(2):142-151. PubMed ID: 37288515
    [Abstract] [Full Text] [Related]

  • 4. Improving the Interpretation of Afternoon Cortisol Levels and SSTs to Prevent Misdiagnosis of Adrenal Insufficiency.
    Ramadoss V, Lazarus K, Prevost AT, Tan T, Meeran K, Choudhury S.
    J Endocr Soc; 2021 Nov 01; 5(11):bvab147. PubMed ID: 34611573
    [Abstract] [Full Text] [Related]

  • 5. Recalibration of thinking about adrenocortical function assessment: how the 'random' cortisol relates to the short synacthen test results.
    Michaelidou M, Yadegarfar G, Morris L, Dolan S, Robinson A, Naseem A, Livingston M, Duff CJ, Trainer P, Fryer AA, Heald AH.
    Cardiovasc Endocrinol Metab; 2021 Jun 01; 10(2):137-145. PubMed ID: 34113799
    [Abstract] [Full Text] [Related]

  • 6. Validation of the 1 μg short synacthen test: an assessment of morning cortisol cut-off values and other predictors.
    Perton FT, Mijnhout GS, Kollen BJ, Rondeel JM, Franken AA, Groeneveld PH.
    Neth J Med; 2017 Jan 01; 75(1):14-20. PubMed ID: 28124663
    [Abstract] [Full Text] [Related]

  • 7. The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis.
    Hurel SJ, Thompson CJ, Watson MJ, Harris MM, Baylis PH, Kendall-Taylor P.
    Clin Endocrinol (Oxf); 1996 Feb 01; 44(2):141-6. PubMed ID: 8849566
    [Abstract] [Full Text] [Related]

  • 8. A time-adjusted cortisol cut-off can reduce referral rate for Synacthen stimulation test whilst maintaining diagnostic performance.
    Brown S, Hadlow N, Badshah I, Henley D.
    Clin Endocrinol (Oxf); 2017 Nov 01; 87(5):418-424. PubMed ID: 28653409
    [Abstract] [Full Text] [Related]

  • 9. Do we need 30 min cortisol measurement in the short synacthen test: a retrospective study.
    Kumar R, Carr P, Moore K, Rajput Z, Ward L, Wassif WS.
    Postgrad Med J; 2020 Aug 01; 96(1138):467-472. PubMed ID: 31810992
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.
    Abdu TA, Elhadd TA, Neary R, Clayton RN.
    J Clin Endocrinol Metab; 1999 Mar 01; 84(3):838-43. PubMed ID: 10084558
    [Abstract] [Full Text] [Related]

  • 11. The Short Synacthen (Corticotropin) Test Can Be Used to Predict Recovery of Hypothalamo-Pituitary-Adrenal Axis Function.
    Pofi R, Feliciano C, Sbardella E, Argese N, Woods CP, Grossman AB, Jafar-Mohammadi B, Gleeson H, Lenzi A, Isidori AM, Tomlinson JW.
    J Clin Endocrinol Metab; 2018 Aug 01; 103(8):3050-3059. PubMed ID: 29846658
    [Abstract] [Full Text] [Related]

  • 12. Sixty-minute post-Synacthen serum cortisol level: a reliable and cost-effective screening test for excluding adrenal insufficiency compared to the conventional short Synacthen test.
    Mansoor S, Islam N, Siddiqui I, Jabbar A.
    Singapore Med J; 2007 Jun 01; 48(6):519-23. PubMed ID: 17538749
    [Abstract] [Full Text] [Related]

  • 13. A retrospective review of the short Synacthen test in Queensland hospitals.
    Wootton E, Truong Q, Pretorius CJ, Balcerek M, Lazarus S.
    Intern Med J; 2024 Sep 01; 54(9):1515-1522. PubMed ID: 38660891
    [Abstract] [Full Text] [Related]

  • 14. How good is a morning cortisol in predicting an adequate response to intramuscular synacthen stimulation?
    Yo WS, Toh LM, Brown SJ, Howe WD, Henley DE, Lim EM.
    Clin Endocrinol (Oxf); 2014 Jul 01; 81(1):19-24. PubMed ID: 24274236
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic-pituitary-adrenal axis suppression - The value of salivary cortisol and cortisone in assessing hypothalamic-pituitary-adrenal recovery.
    Kalaria T, Agarwal M, Kaur S, Hughes L, Sharrod-Cole H, Chaudhari R, Gherman-Ciolac C, Chopra R, Okeke V, Ford C, Buch H, Gama R.
    Ann Clin Biochem; 2020 Nov 01; 57(6):456-460. PubMed ID: 32961064
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of the short Synacthen test: what is the role of the 60 min sample in clinical practice?
    Dineen R, Mohamed A, Gunness A, Rakovac A, Cullen E, Barnwell N, Neary C, Behan LA, Boran G, Gibney J, Sherlock M.
    Postgrad Med J; 2020 Feb 01; 96(1132):67-72. PubMed ID: 31554730
    [Abstract] [Full Text] [Related]

  • 17. Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays.
    Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B, Jafar-Mohammadi B, Grossman AB.
    Clin Endocrinol (Oxf); 2017 Feb 01; 86(2):177-184. PubMed ID: 27616279
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic performance of morning serum cortisol as an alternative to short synacthen test for the assessment of adrenal reserve; a retrospective study.
    Kumar R, Carr P, Wassif W.
    Postgrad Med J; 2022 Feb 01; 98(1156):113-118. PubMed ID: 33122342
    [Abstract] [Full Text] [Related]

  • 19. Basal serum cortisol levels predict a normal response to the Synacthen stimulation test in hospitalised patients.
    Tolkin L, Vidberg M, Munter G.
    Intern Med J; 2022 Jan 01; 52(1):105-109. PubMed ID: 32833270
    [Abstract] [Full Text] [Related]

  • 20. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.
    Woods CP, Argese N, Chapman M, Boot C, Webster R, Dabhi V, Grossman AB, Toogood AA, Arlt W, Stewart PM, Crowley RK, Tomlinson JW.
    Eur J Endocrinol; 2015 Nov 01; 173(5):633-42. PubMed ID: 26294794
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.